Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))

Hoi Wing Leung; Eunice Yuen Ting Lau; Carmen Oi Ning Leung; Martina Mang Leng Lei; Etienne Ho Kit Mok; Victor Wan San Ma; William Chi Shing Cho; Irene Oi Lin Ng; Jing Ping Yun; Shao Hang Cai; Hua Jian Yu; Stephanie Ma; Terence Kin Wah Lee

doi:10.1016/j.canlet.2020.06.007

Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))

Hoi Wing Leung
, Eunice Yuen Ting Lau
, Carmen Oi Ning Leung
, Martina Mang Leng Lei
, Etienne Ho Kit Mok
, Victor Wan San Ma
, William Chi Shing Cho
, Irene Oi Lin Ng
, Jing Ping Yun
, Shao Hang Cai
, Hua Jian Yu
, Stephanie Ma
, Terence Kin Wah Lee (Corresponding Author)

The Hong Kong Polytechnic University

Research output: Journal article publication › Comment/debate/erratum

Abstract

The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read “This study was supported by the RGC General Research Fund (17120215)”. The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	2
Number of pages	1
Journal	Cancer Letters
Volume	499
DOIs	https://doi.org/10.1016/j.canlet.2020.06.007
Publication status	Published - 28 Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

More information

10.1016/j.canlet.2020.06.007

http://hdl.handle.net/10397/95232

Fingerprint

Dive into the research topics of 'Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))'. Together they form a unique fingerprint.

Cite this

Leung, H. W., Lau, E. Y. T., Leung, C. O. N., Lei, M. M. L., Mok, E. H. K., Ma, V. W. S., Cho, W. C. S., Ng, I. O. L., Yun, J. P., Cai, S. H., Yu, H. J., Ma, S., & Lee, T. K. W. (2021). Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008)). Cancer Letters, 499, 2. https://doi.org/10.1016/j.canlet.2020.06.007

Leung, Hoi Wing ; Lau, Eunice Yuen Ting ; Leung, Carmen Oi Ning et al. / Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008)). In: Cancer Letters. 2021 ; Vol. 499. pp. 2.

@article{f57b87f5ab474ebe961e79bc61c27ce4,

title = "Corrigendum to {\textquotedblleft}NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma{\textquotedblright} [Canc. Lett. 476 (2020) 48{\textendash}56] (Cancer Letters (2020) 476 (48{\textendash}56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))",

abstract = "The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read {\textquotedblleft}This study was supported by the RGC General Research Fund (17120215){\textquotedblright}. The authors would like to apologise for any inconvenience caused.",

author = "Leung, \{Hoi Wing\} and Lau, \{Eunice Yuen Ting\} and Leung, \{Carmen Oi Ning\} and Lei, \{Martina Mang Leng\} and Mok, \{Etienne Ho Kit\} and Ma, \{Victor Wan San\} and Cho, \{William Chi Shing\} and Ng, \{Irene Oi Lin\} and Yun, \{Jing Ping\} and Cai, \{Shao Hang\} and Yu, \{Hua Jian\} and Stephanie Ma and Lee, \{Terence Kin Wah\}",

note = "Funding Information: The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read {\textquotedblleft}This study was supported by the RGC General Research Fund ( 17120215 ){\textquotedblright}. The authors would like to apologise for any inconvenience caused. Funding Information: The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read ?This study was supported by the RGC General Research Fund (17120215)?. The authors would like to apologise for any inconvenience caused. Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",

year = "2021",

month = feb,

day = "28",

doi = "10.1016/j.canlet.2020.06.007",

language = "English",

volume = "499",

pages = "2",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

}

Leung, HW, Lau, EYT, Leung, CON, Lei, MML, Mok, EHK, Ma, VWS, Cho, WCS, Ng, IOL, Yun, JP, Cai, SH, Yu, HJ, Ma, S & Lee, TKW 2021, 'Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))', Cancer Letters, vol. 499, pp. 2. https://doi.org/10.1016/j.canlet.2020.06.007

Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008)). / Leung, Hoi Wing; Lau, Eunice Yuen Ting; Leung, Carmen Oi Ning et al.
In: Cancer Letters, Vol. 499, 28.02.2021, p. 2.

Research output: Journal article publication › Comment/debate/erratum

TY - JOUR

T1 - Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))

AU - Leung, Hoi Wing

AU - Lau, Eunice Yuen Ting

AU - Leung, Carmen Oi Ning

AU - Lei, Martina Mang Leng

AU - Mok, Etienne Ho Kit

AU - Ma, Victor Wan San

AU - Cho, William Chi Shing

AU - Ng, Irene Oi Lin

AU - Yun, Jing Ping

AU - Cai, Shao Hang

AU - Yu, Hua Jian

AU - Ma, Stephanie

AU - Lee, Terence Kin Wah

N1 - Funding Information: The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read “This study was supported by the RGC General Research Fund ( 17120215 )”. The authors would like to apologise for any inconvenience caused. Funding Information: The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read ?This study was supported by the RGC General Research Fund (17120215)?. The authors would like to apologise for any inconvenience caused. Publisher Copyright: © 2020 Elsevier B.V.

PY - 2021/2/28

Y1 - 2021/2/28

N2 - The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read “This study was supported by the RGC General Research Fund (17120215)”. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read “This study was supported by the RGC General Research Fund (17120215)”. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85086573308

U2 - 10.1016/j.canlet.2020.06.007

DO - 10.1016/j.canlet.2020.06.007

M3 - Comment/debate/erratum

C2 - 32563702

AN - SCOPUS:85086573308

SN - 0304-3835

VL - 499

SP - 2

JO - Cancer Letters

JF - Cancer Letters

ER -

Leung HW, Lau EYT, Leung CON, Lei MML, Mok EHK, Ma VWS et al. Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008)). Cancer Letters. 2021 Feb 28;499:2. doi: 10.1016/j.canlet.2020.06.007

Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))

Abstract

UN SDGs

ASJC Scopus subject areas

More information

Other files and links

Fingerprint

Cite this